文献速递神经核医学肿瘤 PET/CT

基于深度代谢影像指标对帕金森综合征的鉴别诊断

Differential Diagnosis of Parkinsonism Based on Deep Metabolic Imaging Indices.
PubMed 文献 · J Nucl Med · 2022-03-03

研究基于华山帕金森病PET影像数据库(含1275例帕金森病患者和863例非帕金森病受试者的18F-FDG PET图像)建立3维深度卷积神经网络提取深度代谢影像(DMI)指标,并在独立盲测队列及外部德国队列(90例帕金森病患者)中评估。DMI指标在盲测队列中对特发性帕金森病(IPD)、多系统萎缩(MSA)和进行性核上性麻痹(PSP)诊断的灵敏度分别为98.1%、88.5%、84.5%,特异度分别为90.0%、99.2%、97.8%;在德国队列中灵敏度分别为94.1%、82.4%、82.1%,特异度分别为84.0%、99.9%、94.1%。结论认为DMI指标有潜力为帕金森综合征提供早期、准确的鉴别诊断,并在处理人群和影像采集差异时表现稳健。

要点

  • DMI指标在盲测队列中对IPD、MSA、PSP的灵敏度分别为98.1%、88.5%、84.5%,特异度分别为90.0%、99.2%、97.8%。
  • 在外部德国队列中,DMI指标对IPD、MSA、PSP的灵敏度分别为94.1%、82.4%、82.1%,特异度分别为84.0%、99.9%、94.1%。
  • 仅使用PET扫描即可达到与将人口学和临床信息整合入DMI指标相当的性能。

核心结论

  • 基于HPPI数据库开发的DMI指标有潜力为帕金森综合征提供早期、准确的鉴别诊断,并在处理人群和影像采集差异时表现稳健。

研究设计与样本

  • 建立华山帕金森病PET影像(HPPI,中国)数据库,含1275例帕金森病患者和863例非帕金森病受试者的18F-FDG PET图像,用于支持人工智能开发。
  • 开发3维深度卷积神经网络提取深度代谢影像(DMI)指标,并在来自HPPI的独立纵向随访队列及外部德国队列(90例帕金森病患者,不同影像采集方案)中进行盲法评估。

主要发现

  • 在盲测队列中,DMI指标对IPD、MSA、PSP诊断的灵敏度分别为98.1%、88.5%、84.5%,特异度分别为90.0%、99.2%、97.8%。
  • 在德国队列中,DMI指标对IPD、MSA、PSP诊断的灵敏度分别为94.1%、82.4%、82.1%,特异度分别为84.0%、99.9%、94.1%。
  • 仅使用PET扫描即可达到与将人口学和临床信息整合入DMI指标相当的性能。

关键数值与推荐

  • 盲测队列:IPD灵敏度98.1%、特异度90.0%;MSA灵敏度88.5%、特异度99.2%;PSP灵敏度84.5%、特异度97.8%。
  • 德国队列:IPD灵敏度94.1%、特异度84.0%;MSA灵敏度82.4%、特异度99.9%;PSP灵敏度82.1%、特异度94.1%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The clinical presentations of early idiopathic Parkinson disease (IPD) substantially overlap with those of atypical parkinsonian syndromes such as multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). This study aimed to develop metabolic imaging indices based on deep learning to support the differential diagnosis of these conditions. Methods: A benchmark Huashan parkinsonian PET imaging (HPPI, China) database including 1,275 parkinsonian patients and 863 nonparkinsonian subjects with 18F-FDG PET images was established to support artificial intelligence development. A 3-dimensional deep convolutional neural network was developed to extract deep metabolic imaging (DMI) indices and blindly evaluated in an independent cohort with longitudinal follow-up from the HPPI and an external German cohort of 90 parkinsonian patients with different imaging acquisition protocols. Results: The proposed DMI indices had less ambiguity space in the differential diagnosis. They achieved sensitivities of 98.1%, 88.5%, and 84.5%, and specificities of 90.0%, 99.2%, and 97.8%, respectively, for the diagnosis of IPD, MSA, and PSP in the blind-test cohort. In the German cohort, they resulted in sensitivities of 94.1%, 82.4%, and 82.1%, and specificities of 84.0%, 99.9%, and 94.1%, respectively. Using the PET scans independently achieved a performance comparable to the integration of demographic and clinical information into the DMI indices. Conclusion: The DMI indices developed on the HPPI database show the potential to provide an early and accurate differential diagnosis for parkinsonism and are robust when dealing with discrepancies between populations and imaging acquisitions.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Wu P, Zhao Y, Wu J, et al. Differential Diagnosis of Parkinsonism Based on Deep Metabolic Imaging Indices. J Nucl Med. 2022. PMID: 35241481. doi:10.2967/jnumed.121.263029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。